A multi-drug intoxication fatality involving Xyrem® (GHB)

Journal of Forensic Sciences

Volumn 54, Issue 2, 2009, Pages 495-496

  Akins, Brianne E ^a   Miranda, Estuardo ^a   Matthew Lacy, J ^b   Logan, Barry K ^c  

^a Washington State Patrol   (United States)

^b King County Medical Examiner's Office   (United States)

^c NMS Labs   (United States)

Author keywords

Forensic science; Gamma hydroxybutyrate; Overdose; Postmortem; Sleep apnea; Toxicology; Xyrem

Indexed keywords

CARISOPRODOL; CETIRIZINE; GABAPENTIN; MODAFINIL; OXYBATE SODIUM; TRAMADOL;

ACCIDENTAL DEATH; ADULT; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CAUSE OF DEATH; DRUG INTOXICATION; FATALITY; FEMALE; HUMAN; NARCOLEPSY; PRIORITY JOURNAL; SEXUAL CRIME; SLEEP; SLEEP APNEA SYNDROME; SNORING;

AMINES; BENZHYDRYL COMPOUNDS; CARISOPRODOL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CETIRIZINE; CYCLOHEXANECARBOXYLIC ACIDS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FORENSIC TOXICOLOGY; GAMMA-AMINOBUTYRIC ACID; GASTROINTESTINAL CONTENTS; HUMANS; MIDDLE AGED; NARCOLEPSY; SLEEP APNEA SYNDROMES; SNORING; SODIUM OXYBATE; TRAMADOL; VITREOUS BODY;

EID: 60849108326     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2008.00965.x     Document Type: Article

References (11)

1. Mason PE, Kerns WP. Gamma hydroxybutyric acid (GHB) intoxication. Acad Emerg Med 2002 9 (7 730 9.
2. LeBeau MA, Montgomery MA, Miller ML, Burmeister SG. Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS. J Anal Toxicol 2000 24 (6 421 8.
3. Couper FJ, BK Logan. Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography-mass spectrometry. J Anal Toxicol 2000 24 (1 1 7.
4. Robinson DM, Keating GM. Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs 2007 21 (4 337 54.
5. Nishino S. Clinical and neurobiological aspects of narcolepsy. Sleep Med 2007 8 (4 373 99.
6. US Food and Drug Administration. FDA talk paper: FDA approves Xyrem for cataplexy attacks in patients with narcolepsy. http://www.fda.gov/bbs/topics/ ANSWERS/2002/ANS01157.html.
7. Xyrem® physician's desk reference. Greenwood Village, CO : Thompson Micromedex, 2007 1688 92.
8. US Xyrem® Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med 2004 5 (2 119 23.
9. US. Xyrem® Multicenter Study Group. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep 2003 26 (1 31 5.
10. Jazz Pharmaceuticals, Inc. Xyrem® (sodium oxybate) oral solution. Product monograph. Palo Alto, CA : Jazz Pharmaceuticals, 2005, http://jazzph.isat-tech.com/media/PI.pdf.
11. Helrich M, McAslan TC, Skolnick S, Bessman SP. Correlation of blood levels of 4-hydroxybutyrate with state of consciousness. Anesthesiology 1964 25 : 771 5.